Mobile Motivational Messages for Change (3M4Chan) Intervention in TMU
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Type d'étude
Type d'étude
Inscription (Réel)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Taipei, Taïwan, 11031
- Syed Abdul Shabbir
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 20 years or older and approach smoke cessation clinic at TMU hospital
- Have an Android mobile phone
- Able to read Traditional Chinese
- Willing to participate in all study components
- Willing to be followed-up for 6 months
- Smoked at least once every month in the last two years
- Current smoker
Exclusion Criteria:
• Below 20 years on the day of enrolment
- Not willing to participate in the study
- Those who do not have Android mobile phone or unable to read Mandarin
- Not willing to share medical information from EHR
- Subjects who develop adverse effects related to the pharmacological treatment included in the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Comparateur actif: Case
Motivational message will be administrated.
|
Motivational message will be administrated.
|
|
Aucune intervention: Control
Motivational message will not be administrated.
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Smoking cessation rate at two months
Délai: Up to 2 months
|
Smoking cessation rate will be measured as the ratio of the total number of patients who relapsed with total number of patients in their group.
Patients will be considered to have relapsed if they fail at least one of their urine cotinine and carbon monoxide tests.
|
Up to 2 months
|
|
Smoking cessation rate at four months
Délai: Up to 4 months
|
Smoking cessation rate will be measured as the ratio of the total number of patients who relapsed with total number of patients in their group.
Patients will be considered to have relapsed if they fail at least one of their urine cotinine and carbon monoxide tests.
|
Up to 4 months
|
|
Smoking cessation rate at six months
Délai: Up to 6 months
|
Smoking cessation rate will be measured as the ratio of the total number of patients who relapsed with total number of patients in their group.
Patients will be considered to have relapsed if they fail at least one of their urine cotinine and carbon monoxide tests.
|
Up to 6 months
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
User engagement at an individual level
Délai: Up to 6 months
|
Engagement at individual level will be assessed based on the rate of read messages by the patients.
This is calculated as the quotient between the messages the patients have read, and the total number of messages the system has sent to the patients.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
|
Engagement at aggregated level - Mobile application rolling retention
Délai: Up to 6 months
|
The percentage of users still active N days after installation.
This is a ratio of the number of users whose last day of activity is past day N to the number of users who could have been active on day N.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
|
Engagement at aggregated level - Mobile application session length distribution
Délai: Up to 6 months
|
The session length is defined as the length of time between the start of the application event and the end of the application event.
The session length determines the engagement as it is relevant to know how much time patients spend in the app per session.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
|
Engagement at aggregated level - Mobile application session frequency
Délai: Up to 6 months
|
The session frequency is a measure of how often each unique patient used the app within a given time interval.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
|
Engagement at aggregated level - Mobile application sessions per user
Délai: Up to 6 months
|
A session is one use of the mobile application by a patient.
This begins when the application is launched and ends when the application is terminated.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
|
Engagement at aggregated level - Mobile application return rate
Délai: Up to 6 months
|
Return rate measures the percentage of patients who return to the app on a specific time after installation.
It is measured by cohort group - that is, based on when patients first opened the app.
It is calculated as the ratio of the number of users active on a given period to the size of the cohort.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
|
User quitting attempts
Délai: Up to 6 months
|
Number of quitting attempts per patient, including the frequency of the quitting attempts.
|
Up to 6 months
|
|
User app behavior
Délai: Up to 6 months
|
It will be measured as the time spent per app section.
|
Up to 6 months
|
|
User satisfaction with messages
Délai: At 6 months after enrolment.
|
Patients' answers to a satisfaction questionnaire that will be handed to them at the end of the study.
|
At 6 months after enrolment.
|
|
User message ratings
Délai: Up to 6 months
|
User's votes for each message in a 5 star scale.
|
Up to 6 months
|
|
User lifestyle feedback
Délai: At enrollment and at 6 months after enrollment
|
Comparison of changes in user lifestyle (at baseline and after 6 months) through the combined questionnaire EQ-5D-5L.
|
At enrollment and at 6 months after enrollment
|
|
User lifestyle feedback
Délai: At enrollment and at 6 months after enrollment
|
Comparison of changes in user lifestyle (at baseline and after 6 months) through the combined questionnaire IPAQ for physical activity.
|
At enrollment and at 6 months after enrollment
|
|
User lifestyle feedback
Délai: At enrollment and at 6 months after enrollment
|
Comparison of changes in user lifestyle (at baseline and after 6 months) through the combined questionnaires SF-36.
|
At enrollment and at 6 months after enrollment
|
|
Physical activity
Délai: Up to 6 months
|
The physical activity would be measured as the total time (minutes) of activity per user, retrieved by GoogleFit in the app.
|
Up to 6 months
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Réel)
Achèvement primaire
Achèvement de l'étude (Réel)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- N201702069
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .